Community Pharmacy - Gender Dysphoria Medicines - Sefton Place
A Contract Award Notice
by NHS CHESHIRE AND MERSEYSIDE INTEGRATED CARE BOARD
- Source
- Find a Tender
- Type
- Contract (Services)
- Duration
- not specified
- Value
- £0
- Sector
- HEALTH
- Published
- 29 Apr 2026
- Delivery
- not specified
- Deadline
- n/a
Related Terms
Location
Asda 81 Strand Road Bootle Liverpool L20 4BB
2 buyers
1 supplier
- Asda Stores Bootle
Description
Asda Pharmacy will maintain an agreed stock level of medicines used in the treatment of gender dysphoria. This service ensures there is timely access to medicines used in this treatment in a safe and accessible environment. This service is an activity based contract. The pharmacy is reimbursed based on the prescribing of the medications listed within the service specification.
Total Quantity or Scope
NHS Cheshire and Merseyside ICB has awarded a one year contract via Direct Award A to the provider to supply medications in accordance with the service specification across Cheshire and Merseyside. The contract commenced on 1st April 2026 and will expire on the 31st March 2027. The price of the contract is activity based.
Award Detail
| 1 | Asda Stores (Bootle)
|
Award Criteria
| No realistic alternative provider | 99.0 |
| PRICE | 1.0 |
CPV Codes
- 85100000 - Health services
Indicators
- Award on basis of price.
Legal Justification
This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.
Other Information
N/A This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. On the 18th of November 2025 the Finance, Investment, Resources Committee approved this decision and there were no declarations of interest made by members that would materially or adversely impact on matters requiring discussion and decision. The decision to award was made in line with the conflict of interest policy.
Reference
- FTS 039285-2026